US 8058403
Antibodies to stromal cell-derived factor-1 polypeptides
granted A61PA61P11/00A61P17/00
Quick answer
US patent 8058403 (Antibodies to stromal cell-derived factor-1 polypeptides) held by Five Prime Therapeutics, Inc. expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P11/00, A61P17/00, A61P3/10, A61P31/00